CD274 and cancer: Some recent studies show that high doses of apigenin can inhibit the proliferation of DCs, and can also reduce the protein expression of programmed death-ligand 1 (PD-L1) in DCs by inhibiting the phosphorylation of STAT1, thus inducing anti-cancer immunity [48, 49].